2/12
04:05 pm
prta
Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
Low
Report
Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
1/21
07:04 pm
prta
All You Need to Know About Prothena (PRTA) Rating Upgrade to Buy [Yahoo! Finance]
Medium
Report
All You Need to Know About Prothena (PRTA) Rating Upgrade to Buy [Yahoo! Finance]
1/20
12:26 am
prta
How The New Price Target And Partnerships Are Rewriting Prothena's Story [Yahoo! Finance]
Low
Report
How The New Price Target And Partnerships Are Rewriting Prothena's Story [Yahoo! Finance]
1/5
04:38 pm
prta
How Are Partnered Pipelines Rewriting The Prothena (PRTA) Narrative And Price Target Outlook [Yahoo! Finance]
Low
Report
How Are Partnered Pipelines Rewriting The Prothena (PRTA) Narrative And Price Target Outlook [Yahoo! Finance]
1/2
12:25 pm
prta
We Think Prothena (NASDAQ:PRTA) Can Afford To Drive Business Growth [Yahoo! Finance]
Low
Report
We Think Prothena (NASDAQ:PRTA) Can Afford To Drive Business Growth [Yahoo! Finance]
12/30
04:14 pm
prta
Prothena (NASDAQ:PRTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Prothena (NASDAQ:PRTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/12
04:37 pm
prta
Prothena Announces Board of Directors Update [Yahoo! Finance]
Medium
Report
Prothena Announces Board of Directors Update [Yahoo! Finance]
12/12
04:05 pm
prta
Prothena Announces Board of Directors Update
Medium
Report
Prothena Announces Board of Directors Update
12/6
09:21 pm
prta
How the Narrative Surrounding Prothena Is Changing After New Pipeline and Valuation Updates [Yahoo! Finance]
Low
Report
How the Narrative Surrounding Prothena Is Changing After New Pipeline and Valuation Updates [Yahoo! Finance]
12/1
08:35 am
prta
Prothena (NASDAQ:PRTA) had its price target raised by analysts at Citizens Jmp from $11.00 to $19.00. They now have a "market outperform" rating on the stock.
Low
Report
Prothena (NASDAQ:PRTA) had its price target raised by analysts at Citizens Jmp from $11.00 to $19.00. They now have a "market outperform" rating on the stock.
12/1
07:19 am
prta
Prothena (NASDAQ:PRTA) was given a new $19.00 price target on by analysts at Deutsche Bank Aktiengesellschaft.
Medium
Report
Prothena (NASDAQ:PRTA) was given a new $19.00 price target on by analysts at Deutsche Bank Aktiengesellschaft.
12/1
07:19 am
prta
Prothena (NASDAQ:PRTA) was given a new $19.00 price target on by analysts at JMP Securities.
Medium
Report
Prothena (NASDAQ:PRTA) was given a new $19.00 price target on by analysts at JMP Securities.
12/1
06:04 am
prta
Prothena (NASDAQ:PRTA) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Prothena (NASDAQ:PRTA) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
11/22
05:37 am
prta
Why The Narrative Around Prothena Is Shifting After Analysts Raise Targets and Clinical Updates [Yahoo! Finance]
Low
Report
Why The Narrative Around Prothena Is Shifting After Analysts Raise Targets and Clinical Updates [Yahoo! Finance]
11/21
05:31 am
prta
Prothena (NASDAQ:PRTA) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Medium
Report
Prothena (NASDAQ:PRTA) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
11/19
04:34 pm
prta
Prothena Announces Poster Presentation on its TDP-43 CYTOPE® Program at Neuroscience 2025 [Yahoo! Finance]
Low
Report
Prothena Announces Poster Presentation on its TDP-43 CYTOPE® Program at Neuroscience 2025 [Yahoo! Finance]
11/19
04:05 pm
prta
Prothena Announces Poster Presentation on its TDP-43 CYTOPE® Program at Neuroscience 2025
Low
Report
Prothena Announces Poster Presentation on its TDP-43 CYTOPE® Program at Neuroscience 2025
11/18
01:19 pm
prta
Prothena (NASDAQ:PRTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Prothena (NASDAQ:PRTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.